Yide Medical Reports 2020 Net Loss of RMB 14.26 Million Amid Pandemic-Driven Order Decline

Source: Wabei.com

WaBei.com, May 8 – EDER Medical (839056) recently released its 2020 annual report. During the reporting period, the company achieved operating revenue of RMB 19,000,361.75, representing a year-on-year decline of 82.09%. The net profit attributable to shareholders of the listed company amounted to -RMB 14,260,730.34, marking a shift from profit in the previous year to a loss.

During the reporting period, the net cash flow from operating activities amounted to RMB 4,873,126.75, and the net assets attributable to shareholders of the listed company stood at RMB 68,156,726.61 as of the end of 2020.

During the reporting period, operating revenue amounted to RMB 19,000,361.75, representing a year-on-year decline of 82.09%, primarily due to a reduction in orders caused by the pandemic. Operating costs totaled RMB 10,172,778.58, a decrease of RMB 75,661,468.89 compared to the previous period, with a variation rate of 87.89%, mainly attributable to the corresponding reduction in costs resulting from fewer orders amid the pandemic.

According to data from Wabei.com, EDER Medical is driven by high-tech innovation, combining electronic control with mechanical design to research, develop, manufacture, and sell surgical microscopes—the foundational equipment for minimally invasive medical procedures.